Edition:
United Kingdom

Livzon Pharmaceutical Co Announces Change In Shareholding Structure Of Livzon MABPharm


Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::CO & JOINCARE PHARMACEUTICAL INDUSTRY ENTERED FRAMEWORK AGREEMENT RELATING TO CAPITAL CONTRIBUTION TO LIVZON BIOLOGICS.‍ACQUISITION CONSIDERATION OF 100% OF EQUITY INTERESTS OF LIVZON MAB BY BIOLOGICS TO BE RMB600 MILLION​. 

Company Quote

20.85
-0.1 -0.48%
18 Sep 2019